384 related articles for article (PubMed ID: 25917046)
1. Predictors of survival in patients with spinal ependymoma.
Lin Y; Smith ZA; Wong AP; Melkonian S; Harris DA; Lam S
Neurol Res; 2015 Jul; 37(7):650-5. PubMed ID: 25917046
[TBL] [Abstract][Full Text] [Related]
2. Outcomes following myxopapillary ependymoma resection: the importance of capsule integrity.
Abdulaziz M; Mallory GW; Bydon M; De la Garza Ramos R; Ellis JA; Laack NN; Marsh WR; Krauss WE; Jallo G; Gokaslan ZL; Clarke MJ
Neurosurg Focus; 2015 Aug; 39(2):E8. PubMed ID: 26235025
[TBL] [Abstract][Full Text] [Related]
3. Treatment of pediatric Grade II spinal ependymomas: a population-based study.
Lin Y; Jea A; Melkonian SC; Lam S
J Neurosurg Pediatr; 2015 Mar; 15(3):243-9. PubMed ID: 25525932
[TBL] [Abstract][Full Text] [Related]
4. Primary spinal myxopapillary ependymoma in the pediatric population: a study from the Surveillance, Epidemiology, and End Results (SEER) database.
Lucchesi KM; Grant R; Kahle KT; Marks AM; DiLuna ML
J Neurooncol; 2016 Oct; 130(1):133-140. PubMed ID: 27423644
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with progression-free survival and long-term neurological outcome after resection of intramedullary spinal cord tumors: analysis of 101 consecutive cases.
Garcés-Ambrossi GL; McGirt MJ; Mehta VA; Sciubba DM; Witham TF; Bydon A; Wolinksy JP; Jallo GI; Gokaslan ZL
J Neurosurg Spine; 2009 Nov; 11(5):591-9. PubMed ID: 19929363
[TBL] [Abstract][Full Text] [Related]
6. Pathology of spinal ependymomas: an institutional experience over 25 years in 134 patients.
Tarapore PE; Modera P; Naujokas A; Oh MC; Amin B; Tihan T; Parsa AT; Ames CP; Chou D; Mummaneni PV; Weinstein PR
Neurosurgery; 2013 Aug; 73(2):247-55; discussion 255. PubMed ID: 23670032
[TBL] [Abstract][Full Text] [Related]
7. Surgical outcomes in spinal cord ependymomas and the importance of extent of resection in children and young adults.
Safaee M; Oh MC; Mummaneni PV; Weinstein PR; Ames CP; Chou D; Berger MS; Parsa AT; Gupta N
J Neurosurg Pediatr; 2014 Apr; 13(4):393-9. PubMed ID: 24506340
[TBL] [Abstract][Full Text] [Related]
8. Ependymoma of the spinal cord in children and adolescents: a retrospective series from the HIT database.
Benesch M; Weber-Mzell D; Gerber NU; von Hoff K; Deinlein F; Krauss J; Warmuth-Metz M; Kortmann RD; Pietsch T; Driever PH; Quehenberger F; Urban C; Rutkowski S
J Neurosurg Pediatr; 2010 Aug; 6(2):137-44. PubMed ID: 20672934
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes of spinal ependymomas: an institutional experience of more than 60 cases.
Savoor R; Sita TL; Dahdaleh NS; Helenowski I; Kalapurakal JA; Marymont MH; Lukas R; Kruser TJ; Smith ZA; Koski T; Ganju A; Sachdev S
J Neurooncol; 2021 Jan; 151(2):241-247. PubMed ID: 33179213
[TBL] [Abstract][Full Text] [Related]
10. A systematic review of outcome in intramedullary ependymoma and astrocytoma.
Hamilton KR; Lee SS; Urquhart JC; Jonker BP
J Clin Neurosci; 2019 May; 63():168-175. PubMed ID: 30833131
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant radiotherapy delays recurrence following subtotal resection of spinal cord ependymomas.
Oh MC; Ivan ME; Sun MZ; Kaur G; Safaee M; Kim JM; Sayegh ET; Aranda D; Parsa AT
Neuro Oncol; 2013 Feb; 15(2):208-15. PubMed ID: 23229996
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological features of myxopapillary ependymoma.
Wang H; Zhang S; Rehman SK; Zhang Z; Li W; Makki MS; Zhou X
J Clin Neurosci; 2014 Apr; 21(4):569-73. PubMed ID: 24332590
[TBL] [Abstract][Full Text] [Related]
13. Metastases of spinal myxopapillary ependymoma: unique characteristics and clinical management.
Kraetzig T; McLaughlin L; Bilsky MH; Laufer I
J Neurosurg Spine; 2018 Feb; 28(2):201-208. PubMed ID: 29219779
[TBL] [Abstract][Full Text] [Related]
14. An integrative analysis of treatment, outcomes and prognostic factors for primary spinal anaplastic ependymomas.
Chen P; Sui M; Ye J; Wan Z; Chen F; Luo C
J Clin Neurosci; 2015 Jun; 22(6):976-80. PubMed ID: 25769252
[TBL] [Abstract][Full Text] [Related]
15. Ependymoma of the Spinal Cord in Children: A Retrospective French Study.
Szathmari A; Zerah M; Vinchon M; Dufour C; Gimbert E; Di Rocco F; Chabaud S; Conter C; Mottolese C; Frappaz D
World Neurosurg; 2019 Jun; 126():e1035-e1041. PubMed ID: 30877001
[TBL] [Abstract][Full Text] [Related]
16. Cumulative survival analysis of patients with spinal myxopapillary ependymomas in the first 2 decades of life.
Kukreja S; Ambekar S; Sin AH; Nanda A
J Neurosurg Pediatr; 2014 Apr; 13(4):400-7. PubMed ID: 24527863
[TBL] [Abstract][Full Text] [Related]
17. Population based analysis ependymoma patients in Alberta from 1975 to 2007.
Roldán Urgoiti GB; Singh AD; Tsang RY; Nordal RA; Lim G; Chan JA; Starreveld YP; de Robles PA; Biagioni BJ; Hamilton MG; Easaw JC
Can J Neurol Sci; 2014 Nov; 41(6):742-7. PubMed ID: 25382385
[TBL] [Abstract][Full Text] [Related]
18. Myxopapillary ependymoma: a SEER analysis of epidemiology and outcomes.
Bates JE; Choi G; Milano MT
J Neurooncol; 2016 Sep; 129(2):251-8. PubMed ID: 27306443
[TBL] [Abstract][Full Text] [Related]
19. Spinal ependymoma in adults: a multicenter investigation of surgical outcome and progression-free survival.
Wostrack M; Ringel F; Eicker SO; Jägersberg M; Schaller K; Kerschbaumer J; Thomé C; Shiban E; Stoffel M; Friedrich B; Kehl V; Vajkoczy P; Meyer B; Onken J
J Neurosurg Spine; 2018 Jun; 28(6):654-662. PubMed ID: 29521579
[TBL] [Abstract][Full Text] [Related]
20. Clinical presentation and extent of resection impacts progression-free survival in spinal ependymomas.
Davison MA; Lilly DT; Patel AA; Kashkoush A; Chen X; Wei W; Benzel EC; Prayson RA; Chao S; Angelov L
J Neurooncol; 2024 May; 167(3):437-446. PubMed ID: 38438766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
